Inflation is as high as it’s been in decades, but will it stay that way? Wendy Edelberg, director of The Hamilton Project, looks at the data to see what the biggest risks are going forward and what policymakers can do about it.
Evidence shows that the U.S. pays high prices for patent-protected prescription drugs compared to other OECD countries. A new report from the USC-Brookings Schaeffer Initiative on Health Policy looks at four policy approaches to prescription drug pricing that balance incentives to innovate with affordability.
Patients in need of air ambulances are frequently at risk of surprise out-of-network bills averaging nearly $20,000. In a new report, Loren Adler, Conrad Milhaupt, Bich Ly, and Erin Trish document differences in likelihood and magnitude of surprise billing in the air ambulance market, broken down by ownership type.
